Acute Myocardial Infarction: Clinical Trials

74 trials for Acute Myocardial Infarction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

39 completed, 21 unknown, 7 recruiting, 3 active not recruiting. 74 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 474Completed 39, Unknown 21, Recruiting 7, Active not recruiting 3, Terminated 2, Not yet recruiting 1, Withdrawn 1

Follow Acute Myocardial Infarction: new trials by email Literature Review of Acute Myocardial Infarction trials Research Report on Acute Myocardial Infarction

Trials (filtered) newest first · largest first

All 74 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Adenosine Pre-Medication in Primary Percutaneous Coronary Intervention
Adenosine pre-medication, Standard care - ST-Segment Elevation Myocardial Infarction (STEMI), No-Reflow Phenomenon
Phase 4RecruitingNational Institute of Cardiovascular Diseases, Pakistan11482025-06-012026-04-22
Treatment With Apixaban Versus Warfarin in Patients With Left Ventricular Thrombus After Acute Myocardial Infarction
Apixaban, Warfarin - Left Ventricular Thrombus, Acute Myocardial Infarction
Phase 4RecruitingKarolinska Institutet2122025-04-082025-07-01
Effect of Oral Semaglutide on Epicardial and Pericoronary Adipose Tissues in Type 2 Diabetes After Myocardial Infarction
Semaglutide - Diabetic Patients, Acute Myocardial Infarction
Phase 4UnknownUniversity of Sao Paulo General Hospital882024-09-012024-08-26
Effect of infLuenza vaccInation After Myocardial INfArction on Cardiac inflammaTory responsE
Influenza vaccine, Placebo - Acute Myocardial Infarction, Cardiovascular Diseases
Phase 4RecruitingRegion Örebro County902024-04-242026-04-07
Ticagrelor De-escalation Strategy in AMI Patients
De-escalation strategy, Conventional strategy - Acute Myocardial Infarction
Phase 4RecruitingDong-A University23122023-03-272025-10-01
Revascularization Strategy of Multivessel Disease for Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock Undergoing Veno-arterial Extracorporeal Membrane Oxygenator
Culprit lesion only PCI, Immediate multi-vessel PCI - Cardiogenic Shock, Acute Myocardial Infarction
Phase 4RecruitingSamsung Medical Center5602022-11-162024-11-06
Impact of Early PCSK9 Inhibitor Treatment on Heart After Acute Myocardium Infarction
alirocumab, conventional treatment - Acute Myocardial Infarction
Phase 4RecruitingShanghai Tong Ren Hospital1602022-10-012026-01-27
Intervention of Suxiao Jiuxin Pill on Instability of Vulnerable Plaque in Acute Myocardial Infarction
Suxiao Jiuxin Pills, The placebo of Suxiao Jiuxin Pills - Acute Myocardial Infarction
Phase 4Not yet recruitingXiaolu Li1162022-08-012022-07-20
Optimal Dosage of Ticagrelor in Korean Patients With AMI
Clopidogrel 75 mg, Ticagrelor 60mg, Ticagrelor 45 mg - Acute Myocardial Infarction, Ticagrelor
Phase 4UnknownDong-A University1202022-01-012022-01-27
The OPTIMA-5 Trail
Recombinant Staphylokinase, normal saline - Acute Myocardial Infarction
Phase 4CompletedThe First Affiliated Hospital with Nanjing Medical University2002021-10-292023-01-13
Beta Blocker De-prescription Following Coronary Artery Bypass Graft Surgery (BEEFBURGER Trial).
De-prescribe beta blocker therapy - Coronary Artery Disease, Acute Myocardial Infarction
Phase 4UnknownUniversity of Saskatchewan2002021-08-232022-11-09
Effect of Shexiang Tongxin Dropping Pills on Microcirculation in Patients With AMI
Shexiang Tongxin Dropping Pills + routine treatment, routine treatment - Acute Myocardial Infarction
Phase 4UnknownPeking University Third Hospital602021-08-012021-07-07
Peri-treatment of SGLT-2 Inhibitor on Myocardial Infarct Size and Remodeling Index in Patients With Acute Myocardial Infarction and High Risk of Heart Failure Undergoing Percutaneous Coronary Intervention
SGLT2 inhibitor, Control - Acute Myocardial Infarction, Heart Failure
Phase 4RecruitingSamsung Medical Center2002021-07-052025-06-26
VerifyNow to Optimise Platelet Inhibition in Coronary Acute Syndrome
Clopidogrel, Previous treatment - Acute Coronary Syndrome, Acute Myocardial Infarction
Phase 4CompletedFundación EPIC6372021-07-022026-09-22
HOST - DAPT Duration According the Bleeding Risk
Dual antiplatelet agent duration - Coronary Artery Disease, Acute Myocardial Infarction
Phase 4Active not recruitingSeoul National University Hospital49002020-07-242025-07-23
Optimized Antithrombotic Therapy of Acute Myocardial Infarction With Left Ventricular Mural Thrombus
Combination of antiplatelet drugs and anticoagulants for at least one month - Acute Myocardial Infarction, Left Ventricular Thrombus
Phase 4UnknownThe First Affiliated Hospital with Nanjing Medical University1202020-06-012020-02-11
China Tongxinluo Study for Myocardial Protection in Patients With Acute Myocardial Infarction
Tongxinluo, Placebos - Acute Myocardial Infarction
Phase 4UnknownChina National Center for Cardiovascular Diseases37962019-05-232019-07-31
Danish Trial of Beta Blocker Treatment After Myocardial Infarction Without Reduced Ejection Fraction
Metoprolol Succinate, Bisoprolol, Carvedilol - Acute Myocardial Infarction, Non-ST Elevation Myocardial Infarction (nSTEMI)
Phase 4Active not recruitingBispebjerg Hospital27602018-12-172025-06-10
BEtablocker Treatment After Acute Myocardial Infarction in Patients Without Reduced Left Ventricular Systolic Function
Non-betablocker, Betablocker - Acute Myocardial Infarction, Non-ST Elevation Myocardial Infarction
Phase 4Active not recruitingOslo University Hospital28952018-10-012025-06-08
Dual Antiplatelet Therapy For Shock Patients With Acute Myocardial Infarction
Cangrelor, Ticagrelor - Acute Myocardial Infarction, Cardiogenic Shock
Phase 4CompletedFaculty Hospital Kralovske Vinohrady6052018-08-012025-04-02

Showing 20 of 74. Sign in to see all of them.

Narrower conditions

ST Elevation Myocardial Infarction (11)  ·  Acute Coronary Syndrome (7)  ·  Myocardial Infarction (7)  ·  Non-ST Elevated Myocardial Infarction (5)  ·  Coronary Artery Disease (4)  ·  Diabetes Mellitus (3)  ·  Shock, Cardiogenic (3)  ·  Ventricular Remodeling (3)  ·  Cardiovascular Diseases (2)  ·  Heart Diseases (2)  ·  Infarction (2)  ·  Myocardial Ischemia (2)  ·  No-Reflow Phenomenon (2)  ·  Angina, Stable (1)  ·  Angina, Unstable (1)

Broader conditions

Cardiovascular Diseases (30)  ·  Heart Diseases (29)  ·  Vascular Diseases (29)  ·  Myocardial Ischemia (27)  ·  Pathological Conditions, Signs and Symptoms (26)  ·  Pathologic Processes (22)  ·  Ischemia (20)  ·  Necrosis (20)  ·  Infarction (18)  ·  Myocardial Infarction (13)  ·  Arterial Occlusive Diseases (4)  ·  Arteriosclerosis (4)  ·  Coronary Disease (4)  ·  Endocrine System Diseases (4)  ·  Metabolic Diseases (4)

Interventions

Clopidogrel (7)  ·  Ticagrelor (5)  ·  Tirofiban (5)  ·  Abciximab (3)  ·  Atorvastatin (3)  ·  Metoprolol (3)  ·  2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine (2)  ·  Bisoprolol (2)  ·  Colchicine (2)  ·  Esomeprazole (2)  ·  Famotidine (2)  ·  Sodium Chloride (2)  ·  Streptokinase (2)  ·  reteplase (2)  ·  Acetylcysteine (1)

Sponsors

Ospedale San Donato (3)  ·  Samsung Medical Center (3)  ·  University of Luebeck (3)  ·  Dong-A University (2)  ·  G.Gennimatas General Hospital (2)  ·  Guangdong Provincial Hospital of Traditional Chinese Medicine (2)  ·  Istanbul University (2)  ·  Karolinska Institutet (2)  ·  Ruttonjee Hospital (2)  ·  The First Affiliated Hospital with Nanjing Medical University (2)  ·  Yonsei University (2)  ·  A.O. Ospedale Papa Giovanni XXIII (1)  ·  Ajou University School of Medicine (1)  ·  Bispebjerg Hospital (1)  ·  Catharina Ziekenhuis Eindhoven (1)

Countries

China (12)  ·  South Korea (12)  ·  Italy (8)  ·  Germany (6)  ·  Sweden (4)  ·  Czechia (3)  ·  Japan (3)  ·  Netherlands (3)  ·  Poland (3)  ·  Spain (3)  ·  Turkey (Türkiye) (3)  ·  United Kingdom (3)  ·  Brazil (2)  ·  Canada (2)  ·  Denmark (2)

Top investigators

Berrin Umman, Prof. (2)  ·  Fook Hong Ng, MBBS (2)  ·  Giulio Guagliumi, MD (2)  ·  Leonardo Bolognese, MD, FESC (2)  ·  Sabahattin Umman, Prof. (2)  ·  Ahmet K Bilge, M.D. (1)  ·  Ake Ohlsson, M.D. PhD (1)  ·  Anna Meta D Kristensen, MD (1)  ·  Arif O Cimen, M.D. (1)  ·  B. Rensing, MD, PhD (1)  ·  Bertil Lindahl, MD PhD (1)  ·  Bruno Scheller, MD (1)

Results publications

PMID 36526898, PMID 40888716, PMID 41934630, PMID 10709908, PMID 12932593, PMID 15745837, PMID 15841305, PMID 1627164, PMID 16271642, PMID 16271643, PMID 16515501, PMID 16569536, PMID 16951276, PMID 17045887, PMID 17184583, PMID 17470709, PMID 17476008, PMID 17549308, PMID 17925603, PMID 18227478, PMID 18940887, PMID 19246588, PMID 19726437, PMID 19744615, PMID 19812399, PMID 19829124, PMID 20199815, PMID 20448126, PMID 20619238, PMID 20691839, PMID 20834185, PMID 20971744, PMID 21593301, PMID 21670242, PMID 21712524, PMID 22093203, PMID 22108447, PMID 22440498, PMID 22980307, PMID 23998121, PMID 24719126, PMID 24831770, PMID 25129664, PMID 25147029, PMID 25148231, PMID 25775052, PMID 25890582, PMID 26265659, PMID 26376600, PMID 26482376

NIH funding

2018 (3)